OTLK

Outlook Therapeutics, Inc.NASDAQHealthcare

$0.22+4.29%ClosedMarket Cap: $9.0M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-11	Ascendiant Capital	—	Buy	—
2026-02-18	Chardan Capital	—	Neutral	—
2026-02-18	HC Wainwright & Co.	—	Neutral	—
2026-01-05	Chardan Capital	—	Neutral	—
2026-01-02	HC Wainwright & Co.	—	Neutral	—
2025-12-22	Ascendiant Capital	—	Buy	—
2025-09-30	HC Wainwright & Co.	—	Neutral	—
2025-09-22	Ascendiant Capital	—	Buy	—
2025-08-29	Guggenheim	—	Neutral	—
2025-08-29	HC Wainwright & Co.	—	Neutral	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Sep 30	$-0.28	$58.0M	3
Sat Sep 30	$-0.15	$22.8M	1
Sun Sep 30	$-0.12	$29.7M	1
Mon Sep 30	$-0.13	$30.3M	1

OTLK | Outlook Therapeutics, Inc. Analyst Ratings & Price Target - InvestLog